J Gynecol Oncol.
2020 Mar;31(2):e20. 10.3802/jgo.2020.31.e20.
Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis
- Affiliations
-
- 1Manipal Institute of Virology, Manipal Academy of Higher Education, Manipal, India. sabeenauthradam@gmail.com
- 2Gyneconcology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, India.
- 3Department of Radiation Oncology, Government Medical College, Kozhikode, India.
- 4Department of Statistics, Manipal Academy of Higher Education, Manipal, India.
- KMID: 2470871
- DOI: http://doi.org/10.3802/jgo.2020.31.e20
Abstract
OBJECTIVE
The causal association of human papillomavirus (HPV) in uterine cervical cancer was well established and this oncogenic virus was reported to be a biomarker for overall recurrence and central pelvic recurrence. The objective of the present systematic review and meta-analysis was to assess the role of HPV DNA testing in early detection of recurrence among cervical cancer survivors after radiotherapy.
METHODS
We performed a systematic review and meta-analysis by means of searching electronic databases for published articles between January 1984 and June 2018, on the basis of standard systematic review guidelines prescribed by major agencies namely Cochrane Collaboration (https://www.cochrane.org) and Campbell Collaboration (https://www.campbellcollaboration.org). The meta-analysis component was further modified appropriately for the synthesis of sensitivity and specificity results.
RESULTS
A total of 1,055 cervical cancer cases who had received pelvic radiation with or without chemotherapy from ten cohort studies were evaluated. The overall pooled sensitivity and specificity of HPV DNA testing was 0.84 (95% confidence interval [CI]= 0.66-0.94) and 0.35 (95% CI=0.20-0.54) respectively. The positive likelihood ratio was 1.3 (95% CI=1.0-1.7) and the negative likelihood ratio was 0.45 (95% CI=0.18-1.10) with an estimated diagnostic odds ratio of 3 (95% CI=1-9).
CONCLUSION
The screening for HPV DNA testing during follow-up facilitates early detection of recurrence after radiotherapy.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Detection of Human Papilloma Virus Type 16 and 18 in Adenocarcinoma in situ of the Uterine Cervix
- Clinical significance of human papillomavirus genotyping
- Detection Rate and Prognostic Significance of Human Papillomavirus Type 16 and Type 18 using PCR Method in Uterine Cervical Cancer
- Clinical Efficacy of HPV DNA Chip test in Human papillomavirus detection of Uterine Cervix
- Detection of Human Papillomavirus in Uterine Cervical Cancer Tissues by Polymerase Chain Reaction, In Situ Hybridization and Polymerase Chain Reaction In Situ Techniques
